e

s

c

This site contains all information and links about:
(Please scroll or follow the text links)
Abstract Submission
Subject Areas
Deadlines
Instructions
ESC Anonymous Review Process
Abstract Submission Form Closed!
Abstract Submission Form for "Ongoing Trials" Closed!
Abstract Submission form for nurses and AHP's Closed!

 

• ESC Abstract Submission

The Programme Committee invites authors to submit abstracts for consideration
for inclusion in the programme. Only original, unpublished material will be considered.
Submission of abstracts starts by  October 2007 and implies
that the author(s) accept(s) the conditions laid down, including any conditions relating to
transfer of copyright, and agree(s) to abide by the deadlines specified. All abstracts must be in English.
Abstracts can be sent via online form and  via SP1.1 - Submission Programme only!
There is  a special abstract submission offer for the subject area  " Ongoing trials" only!
Only posters,  publication is on the ESC website , no review process, late submission permitted! Please use the special formular for "Ongoing Trials" or the SP 1.1 to submit your abstract.

Abstract submission online form   Closed!

Abstract submission SP 1.1.2008 programme

Abstract submission online form for "Ongoing Trials"Closed!

Abstract submission form for Nurses – Physiotherapists – Speech and Occupational Therapists - Study/Monitoring Assistants  Closed!

 

Deadlines for the 17th ESC, Nice, France 13- 16 May 2008:

• Deadline for abstract submission:
  January 13, 2008, 24:00 midnight, Central European time

• Deadline for "Ongoing Trials"
  May 5th, 2008, 24:00 midnight, Central European time
   

• Deadline for the 2nd Stroke Meeting for Nurses – Physiotherapists – Speech and Occupational Therapists - Study/Monitoring Assistants
  April 20th, 2008, 24:00 midnight, Central European time

 

Instructions

• Abstracts may only be submitted via Internet.
• Avoid submitting your abstract at the" last minute" which has proved to cause
  overload difficulties with the server/database!
• Abstracts should contain original material only,  which has not been published elsewhere!
• The background and the goals of the study should be apparent clearly to the reader.
  The methods and results must contain original data and the conclusions must be clearly expressed.
• All abbreviations must be defined the first time they appear in your text. Example: Transcranial Doppler (TCD), before being used as an abbreviation only.
• Avoid complex mathematical formulae. For the plus minus symbols, type +/- instead of ±.
  Avoid Greek letters and symbols. Instead of 'IFN-' use for example 'IFN-g' or 'IFN-gamma'.
• When preparing your abstract, bear in mind that it will not only be read by experts in your field but also by colleagues who may not be familiar with your topic.
• Abstracts submitted by fax will not be accepted.
• Abstract title, authors, institution and text (structured as:  Background, Methods, Results, Discussion) should be preformed using your text editor directly on the formular space indicated by means of US/West European script language.
  (Abstract title max.180 characters/signs; Abstract max. 1800 characters/signs.)
  Please make sure that your abstract is in an accurate form because 
  it will be published exactly as submitted!
• "Platform" preferred implies that your abstract will be considered for
  poster presentation as well as for the platform programme.
• "Poster" preferred implies that your abstract will be considered for poster
  presentation as well as for the platform programme.
• Oral Sessions: Platform presentations will be of eight minutes duration followed by
  a two minutes discussion period.
• Poster Sessions: Posters will be displayed in two sessions and authors must
  be available for discussion during the poster sessions.
• Press the send button.
• Get the confirmation of the entery of your abstract and get the AID (Abstract Identification Number) by following the confirmation link.

• Abstracts received after the given deadline will not be reviewed.
  After sending the material you  have to get your abstract identification number 'AID'(Abstract Identification Number / AID = confirmation of the reception of the abstract and for the entering into the review process), confirming that your abstract has been submitted and entered into the review process.  Abstracts without an AID will not be entered into the review process and can not be accepted!  Therefore, please inform us before the deadline passes by (January 13, 2008) if you haven’t received a confirmation AID !Late entries (after January 13, 2008) will only be possible under special circumstances. 
  Please contact: hennerici@eurostroke.eu
  
   

   
   

• Subject Areas for the 17th ESC in Nice, France 2008:
   

  1	Epidemiology of stroke
  2	Risk factors of stroke
  3	Stroke and metabolic syndrome (diabetes, lipids, endothelial dysfunction etc) - original work  new
  4	Stroke and metabolic syndrome (diabetes, lipids, endothelial dysfunction etc) - overview and prespectives new
  5	Etiology of stroke
  6	Stroke and infections
  7	Acute stroke: clinical patterns and practise
  8	Acute stroke: early management and stroke units
  9	Acute stroke: complications and early outcome
  10	Acute stroke: treatment concepts
  11	Longterm outcome of stroke
  12	Chronic conditions and recurrences
  13	Vascular imaging: new developments
  14	Prognostic predictors
  15	Brain Imaging: new developments
  16	Interesting cases
  17	Challenging cases new
  18	Recovery and rehabilitation: mechanisms and concepts
  19	Recovery and rehabilitation: practise and trials
  20	Management and economics
  21	Experimental studies - original work  new
  22	Experimental studies - overview and prespectives  new
  23	Vascular Surgery and Neurosurgery/Interventinal Neuroradiology
  24	Intracerebral and subarachnoid bleedings/ Cerebral haemorrhage and SAH
  25	Venous diseases
  26	Ongoing trials -exclusively for poster presentations - late submission encouraged, no review
  27	Heart & brain
  28	Genetic disorders  - original work new
  29	Genetic disorders - overview and prespectives new
  30	Meta-analysis and review papers
  31	Large clinical trials  (RCTs)
  32	Dementia and cognition
  33	Behavior and mood
  34	Vascular biology - original work new
  35	Vascular biology - overview and prespectives new
  36	TIA   new
  37	Very old age (>80 years) and stroke  new
  38	Small vessel disease  new
  39	IMT new
  40	Regional/national stroke aspects ( EU and beyond )  new

• Publications

All accepted abstracts will be published:
Online on our website www.eurostroke.org and  www.archive.eurostroke.org
In the official journal of the European Stroke Council and Conference: Cerebrovascular Diseases
On CD

• ESC Anonymous Review Process

Each abstract will be  reviewed anonymously  by 4 members of the Scientific Committee.There is a range of 10 points for  rating  0 = worst and 10 = best.
The assessment goes by the following principles:

0-1-2- points for originality of work
(background relevance, hypothesis generation)

0-1-2- points for methodology
(degree of complexity, novelty, etc)

0-1-2- points for data presentation
(details, statistics, clarity)

0-1-2- points for clinical/scientific relevance
(as described in the conclusions)

0-1-2- points for overall presentation
(please consider that this predicts the final   form of presentation either orally or as a poster (preferred ways are indicated)

The mean average value from the 4 ratings will be calculated.
As a rule, an abstract is accepted with a mean average value of  >= 5.5 points and rejected with a mean average value of < 5.5 points. The limit of the mean average value (>=5.5 points accepted; <5.5 points rejected) can vary!

                              

BACK